Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,403 | 1,539 | 99.4% |
| Education | $144.28 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,177 | 214 | $0 (2024) |
| ABBVIE INC. | $2,465 | 142 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,445 | 143 | $0 (2024) |
| PFIZER INC. | $2,293 | 131 | $0 (2024) |
| Amgen Inc. | $1,493 | 74 | $0 (2024) |
| Lilly USA, LLC | $1,259 | 72 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,137 | 89 | $0 (2024) |
| GlaxoSmithKline, LLC. | $972.28 | 70 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $770.79 | 40 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $728.59 | 36 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,483 | 181 | ABBVIE INC. ($600.51) |
| 2023 | $3,160 | 171 | AbbVie Inc. ($563.61) |
| 2022 | $3,424 | 184 | Novo Nordisk Inc ($532.18) |
| 2021 | $3,875 | 229 | AbbVie Inc. ($650.05) |
| 2020 | $2,707 | 175 | Allergan, Inc. ($398.27) |
| 2019 | $3,131 | 205 | PFIZER INC. ($465.63) |
| 2018 | $2,868 | 199 | Novo Nordisk Inc ($383.68) |
| 2017 | $2,900 | 200 | AstraZeneca Pharmaceuticals LP ($361.47) |
All Payment Transactions
1,544 individual payment records from CMS Open Payments — Page 1 of 62
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Gastroenterology | ||||||
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.26 | General |
| 12/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: PAIN | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.18 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.02 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: VACCINES | ||||||
| 12/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Biological), FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Vaccines | ||||||
| 11/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Obesity | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.74 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Gastroenterology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: VACCINE | ||||||
| 10/31/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,697 | 4,552 | $894,364 | $272,323 |
| 2022 | 29 | 2,832 | 3,483 | $543,973 | $182,400 |
| 2021 | 26 | 2,169 | 2,640 | $411,065 | $143,484 |
| 2020 | 28 | 2,030 | 2,531 | $386,821 | $115,175 |
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 585 | 1,222 | $245,622 | $77,671 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 492 | 492 | $196,800 | $67,389 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 299 | $118,404 | $30,210 | 25.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 54 | 54 | $46,419 | $15,218 | 32.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 428 | 428 | $24,396 | $8,333 | 34.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 113 | 114 | $24,250 | $8,186 | 33.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 412 | 412 | $23,484 | $8,022 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 51 | 56 | $31,080 | $7,825 | 25.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 571 | 651 | $29,295 | $6,988 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $26,571 | $6,339 | 23.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 22 | 23 | $19,665 | $5,389 | 27.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 116 | 117 | $7,254 | $3,781 | 52.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $8,738 | $2,995 | 34.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 19 | 19 | $11,495 | $2,923 | 25.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 54 | 64 | $10,304 | $2,601 | 25.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $13,414 | $2,449 | 18.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 93 | 120 | $8,520 | $2,057 | 24.1% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 115 | 115 | $5,885 | $2,034 | 34.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $7,572 | $2,020 | 26.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 12 | 12 | $7,140 | $1,795 | 25.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 11 | 11 | $6,446 | $1,729 | 26.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 53 | 53 | $3,286 | $1,713 | 52.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 13 | 13 | $3,341 | $1,037 | 31.0% |
| G0102 | Prostate cancer screening; digital rectal examination | Office | 2023 | 66 | 66 | $4,686 | $998.37 | 21.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 22 | 22 | $2,596 | $890.34 | 34.3% |
About Dr. Greg Denenberg, MD
Dr. Greg Denenberg, MD is a Internal Medicine healthcare provider based in Skokie, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235185299.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greg Denenberg, MD has received a total of $25,547 in payments from pharmaceutical and medical device companies, with $3,483 received in 2024. These payments were reported across 1,544 transactions from 83 companies. The most common payment nature is "Food and Beverage" ($25,403).
As a Medicare-enrolled provider, Denenberg has provided services to 10,728 Medicare beneficiaries, totaling 13,206 services with total Medicare billing of $713,383. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Skokie, IL
- Active Since 05/25/2006
- Last Updated 05/19/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235185299
Products in Payments
- VRAYLAR (Drug) $1,002
- NURTEC ODT (Drug) $767.13
- UBRELVY (Drug) $756.20
- Saxenda (Drug) $742.87
- FARXIGA (Drug) $688.13
- Ozempic (Drug) $679.06
- XIFAXAN (Drug) $660.09
- SYMBICORT (Drug) $647.46
- ELIQUIS (Drug) $640.41
- JARDIANCE (Drug) $624.48
- CHANTIX (Drug) $567.12
- XARELTO (Drug) $557.81
- Otezla (Drug) $516.81
- Wegovy (Drug) $507.18
- PREVNAR 20 (Biological) $472.23
- BREZTRI (Drug) $452.63
- SHINGRIX (Biological) $449.32
- Yupelri (Drug) $407.24
- Aimovig (Biological) $388.24
- LINZESS (Drug) $361.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Skokie
Liana Billings, Md, Mmsc, MD, MMSC
Internal Medicine — Payments: $387,410
Gregory Mishkel, M.d, M.D
Internal Medicine — Payments: $61,716
Dr. Stephen Kashian, Md, MD
Internal Medicine — Payments: $23,403
Dr. Cliff Ireland, D.o, D.O
Internal Medicine — Payments: $22,598
Dr. Gregory Kaczmarek, Md, MD
Internal Medicine — Payments: $22,496
Dr. Anuj Lal, Md, MD
Internal Medicine — Payments: $21,248